These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2134014)

  • 1. The ternary complex: T cell receptor, MHC protein, and immunogenic peptide.
    Rothbard JB
    Semin Immunol; 1990 Sep; 2(5):283-95. PubMed ID: 2134014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
    Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
    Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
    Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
    Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
    Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
    Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.
    Clayberger C; Parham P; Rothbard J; Ludwig DS; Schoolnik GK; Krensky AM
    Nature; 1987 Dec 24-31; 330(6150):763-5. PubMed ID: 3501071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural basis of HLA-associated drug hypersensitivity syndromes.
    Pompeu YA; Stewart JD; Mallal S; Phillips E; Peters B; Ostrov DA
    Immunol Rev; 2012 Nov; 250(1):158-66. PubMed ID: 23046128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer design of T-cell agonist or antagonist glycopeptides: the effect of sugar identity and anomeric configuration on MHC binding.
    Prammer KV; Ertl HC; Otvos L
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):163-70. PubMed ID: 9346848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.
    Bernardeau K; Gouard S; David G; Ruellan AL; Devys A; Barbet J; Bonneville M; Chérel M; Davodeau F
    Eur J Immunol; 2005 Oct; 35(10):2864-75. PubMed ID: 16163672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
    Heemskerk MH; de Paus RA; Lurvink EG; Koning F; Mulder A; Willemze R; van Rood JJ; Falkenburg JH
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6806-11. PubMed ID: 11381117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor structural changes in a mutated human melanoma antigen correspond to dramatically enhanced stimulation of a CD4+ tumor-infiltrating lymphocyte line.
    Sundberg EJ; Sawicki MW; Southwood S; Andersen PS; Sette A; Mariuzza RA
    J Mol Biol; 2002 May; 319(2):449-61. PubMed ID: 12051920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.